People in Japan who received Pfizer Inc.'s COVID-19 vaccine seem to have suffered anaphylaxis at a higher rate than in the United States and Europe, the minister in charge of vaccination efforts said Wednesday. "It's true, this seems to be more than in the United States and Europe," Taro Kono told a parliamentary committee. The health ministry later said an additional eight cases of anaphylaxis, a severe and potentially fatal allergic reaction, were reported, bringing the total to 25 among around 148,000 health care workers who have been inoculated as of Wednesday.
